Semaglutide (Ozempic) / Tirzepatide (Mounjaro)

Originally developed as treatments for type 2 diabetes, both Semaglutide (Ozempic) and Tirzepatide (Mounjaro) have gained widespread attention for their impressive effectiveness in weight loss, with Semaglutide being known as “the worst-kept secret in Hollywood.” These medications work by reducing appetite, enhancing feelings of fullness, and slowing gastric emptying, which collectively help lower caloric intake. As a result, both options offer new hope for individuals struggling with obesity or excess weight.

Both Semaglutide and Tirzepatide are FDA approved.

*As a medical professional with an injectable license, I have a medical director who oversees my administration of Semaglutide (Ozempic) injections to ensure the safety and effectiveness of the treatment for my patients.

Visit includes consultation & prescription provided to qualified individuals by our in-house providers

Semaglutide (Ozempic) and Tirzepatide (Mounjaro) info

Semaglutide (Ozempic)

Semaglutide, widely recognized as Ozempic, is a GLP-1 receptor agonist initially developed to manage type 2 diabetes. In weight loss, it works by mimicking the GLP-1 hormone, which is naturally released after eating to signal fullness and satisfaction to the brain. By stimulating this hormone, Semaglutide reduces appetite, enhances satiety, and slows gastric emptying, effectively curbing food intake and cravings. These effects contribute to a calorie deficit, aiding individuals in losing weight more sustainably. Due to its proven effectiveness, Semaglutide has become a popular and FDA-approved option for those looking to manage obesity and achieve significant weight loss results.

Tirzepatide (Mounjaro)

Tirzepatide, known as Mounjaro, is a dual-action medication originally developed for type 2 diabetes that has shown exceptional promise in weight loss. It works by activating two hormone pathways—GLP-1 and GIP—that regulate appetite and blood sugar. By mimicking these hormones, Tirzepatide helps reduce hunger, enhance feelings of fullness, and slow gastric emptying, which all contribute to a lower caloric intake. This dual mechanism makes Tirzepatide particularly effective for weight loss, helping individuals with obesity or excess weight achieve significant results. Mounjaro is FDA-approved and is emerging as a powerful new option in weight management. Studies have shown that Tirzepatide may cause somewhat fewer or milder gastrointestinal side effects.

FAQ's

What do I need to know AFTER I get my Weight loss injections?

Important Post Care

Remember that everyone is different and you may or may not have reactions or side effects that someone else might experience. 

Following these guidelines can help reduce common side effects and support your body’s adjustment to the medication.